Plasma therapy is a medical procedure that uses the blood of a recovered patient to create antibodies on those infected individuals. Medically known as convalescent plasma therapy.
A study has been conducted in 39 hospitals all over India. The top medical research has come with all these results regarding plasma therapy.
ICMR researchers have done the research. A multi -center and controlled trial has been done from April 22 to July 14 this year.
The trial was itemized with the Clinical Trial Registry of India (CTRI).
1210 patients admitted 39 trial sites were screened. The number of public hospitals was 29 and 14 were private hospitals. All these hospitals including states and union territories.
“Composite primary outcome was achieved in 44 (18.7 per cent) participants in the intervention arm and 41 (17.9 per cent) in the control arm. Mortality was documented in 34 (13.6 per cent) and 31 (14.6 per cent) participants in intervention and control arm, respectively,” the study mentioned.
The study was conducted on 464 randomly enrolled participants. They were hospitalized and were soberly ill. They were confirmed, COVID-19 patients.
- 235 participants were put in the intervention arm.
- 229 participants were in the control arm.
Two doses of 200 ml CP was transfused 24 hours apart in the intervention arm.
According to the study, participants separated randomly either the control or the intervention arm.